Prosecution Insights
Last updated: October 04, 2026

Avantor Performance Materials, LLC

Technology area: Biotechnology & Pharmaceuticals

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Avantor Performance Materials, LLC maintains a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The company currently has 3 pending office actions across its active filings. These actions are distributed among 3 distinct examiners, which indicates that the prosecution workload is spread across several different individuals. Additionally, the portfolio is being reviewed within 3 distinct art units, suggesting that a variety of technical sub-specialties are involved in the company's current patent applications.

The busiest examiner for the portfolio is TRUONG, QUANGLONG N, who is currently handling 1 busiest examiner pending office action. Given that there are 3 pending office actions in total, this examiner is responsible for a portion of the active workload rather than the whole. Practitioners should note that with 3 distinct examiners and 3 distinct art units, the company must manage multiple prosecution tracks simultaneously. This distribution requires a strategy that accounts for the different perspectives and requirements of each examiner and art unit involved in the Biotechnology & Pharmaceuticals sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (33%)
0
Medium (0%)
1
Easy (33%)
1
Unknown (33%)

Rejection Statute Mix

BucketCases
§112 only1 (33%)
Multi-statute (no §101)1 (33%)
No statute on record1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TRUONG, QUANGLONG N 1 78.8% +23.6%
BATES, KEENAN ALEXANDER 1 45.5% +79.5%
BEANE, RANDALL L 1 32.8% +36.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18031517 MEMBRANE RUPTURE COMPOSITIONS AND METHODS OF MAKING AND USING SAME BATES, KEENAN ALEXANDER —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18285918 PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS TRUONG, QUANGLONG N 117d overdue
17911322 POLYPEPTIDE AFFINITY LIGANDS AND METHODS OF USING BEANE, RANDALL L 19d
18031517 MEMBRANE RUPTURE COMPOSITIONS AND METHODS OF MAKING AND USING SAME BATES, KEENAN ALEXANDER —

Top Art Units

Art UnitApps
1615 1
1631 1
1654 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18285918 PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS TRUONG, QUANGLONG N 1615 — Non-Final OA 117d overdue Pending Oct 06, 2023
18031517 MEMBRANE RUPTURE COMPOSITIONS AND METHODS OF MAKING AND USING SAME BATES, KEENAN ALEXANDER 1631 §102§103§112 Non-Final OA — Pending Apr 12, 2023
17911322 POLYPEPTIDE AFFINITY LIGANDS AND METHODS OF USING BEANE, RANDALL L 1654 §112 Final Rejection 19d Pending Sep 13, 2022

Managing Avantor Performance Materials, LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month